WashU antibody treatment protects tau-affected mouse brains without clearing tau
Researchers at Washington University School of Medicine in St. Louis found that an antibody blocking the CXCR3 receptor reduced T-cell entry into the brains of mice with Alzheimer’s-like tau accumulation. After three and a half months of treatment, the mice…
